GLINLICE M1 Tablet is a combination antidiabetic medication used to manage Type 2 Diabetes Mellitus in adults. It combines Glimepiride, a sulfonylurea, and Metformin, a biguanide, to achieve better glycemic control through a dual mechanism of action.

Glimepiride works by stimulating the pancreas to release more insulin, helping to lower blood glucose levels, especially after meals. On the other hand, Metformin (Prolonged Release) works by decreasing hepatic glucose production and improving insulin sensitivity, allowing better glucose uptake and utilization in the body.

This combination is ideal for patients who are unable to control their blood sugar levels with Metformin alone and require an additional boost in insulin secretion. It helps in lowering both fasting blood glucose (FBG) and postprandial blood glucose (PPBG), and is typically used alongside dietary management and physical activity.